SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Interest Income Over TimeExpanding
Percentile Rank100
3Y CAGR+172.1%
5Y CAGR+122.7%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+172.1%/yr
Annual compound
5Y CAGR
+122.7%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
54.8x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.43M | +11.4% |
| 2024 | $1.29M | +119.8% |
| 2023 | $584966.00 | +723.1% |
| 2022 | $71072.00 | +207.5% |
| 2021 | $23115.00 | -11.5% |
| 2020 | $26131.00 | -76.9% |
| 2019 | $113133.00 | - |